Indications -- Cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1816)	3/6/2018 3:59:53 PM
From: Miljenko Zuanic	Read Replies (1) of 1840

fiercepharma.com <After the newest cut, Opdivo will cost ¥278,000 per 100 milligrams, or about $2,621 at current exchange rates. According to the drug pricing website GoodRx, Opdivo costs around $5,200 in the U.S. for two 100 milligram vials. > So, after this cut Opdivo cost equal in US and Japan. How did they got initial price at ~100% higher in Japan than in US???? https://www.fiercepharma.com/pharma/japan-cuts-opdivo-price-half-as-costs-surge Going forward, Japan may follow more EU steps than US, when come to drug price restriction. Does collaboration fee, that include Japan (Asia) market, indicate this trend?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next